Endoscopic retrograde cholangiopancreatography (ERCP) carries a post-ERCP pancreatitis
(PEP) rate of 2–10%, which could be as high as 30–50% in high-risk cases. PEP is severe in …

Background and Aims The incidence, severity, and mortality of post-ERCP pancreatitis
(PEP) largely remain unknown with changing trends in ERCP use, indication, and …

This review highlights advances made in recent years in the diagnosis and management of
acute pancreatitis (AP). We focus on epidemiological, clinical, and management aspects of …

Background and study aims Endoscopic retrograde cholangiopancreatography (ERCP) is
the primary therapeutic procedure for treatment of diseases that affect the biliary tree and …

Endoscopic retrograde cholangiopancreatography (ERCP) plays a crucial role in the
management of pancreaticobiliary disorders. Although the ERCP technique has been …

Acute post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP) is a feared
and potentially fatal complication that can be as high as up to 30% in high-risk patients. Pre …

Pancreatitis is a serious complication of endoscopic retrograde cholangiopancreatography,
with incidence rates as high as 16% in some centers. Recent studies have also shown an …

Aim: To investigate whether aggressive hydration can increase the efficacy of prophylactic
non-steroid anti-inflammatory drugs (NSAIDs) in prevention of post-ERCP pancreatitis …

Objective: Endoscopic transpapillary or endoscopic ultrasound (EUS)-guided stent
placement is used for nonresectable distal malignant biliary obstruction. We conducted a …

Objective Non-steroidal anti-inflammatory drugs (NSAIDs) are the most studied
chemoprophylaxis for post-endoscopic retrograde cholangiopancreatography pancreatitis …